课题基金 / 基金详情

XAFS STUDIES OF BIOINORGANIC SYSTEMS

XAFS STUDIES OF BIOINORGANIC SYSTEMS
生物无机系统的 XAFS 研究
批准号:
7370432
负责人:
PETER A LAY
金额:
$0.02万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-01 至 2007-02-28

项目摘要

项目成果

PETER A LAY的其他基金

相似基金

相关文献

中文摘要
翻译
本子项目是利用由NIH/NCRR资助的中心赠款提供的资源的众多研究子项目之一。子项目和研究者(PI)可能已经从另一个NIH来源获得了主要资金,因此可以在其他CRISP条目中表示。列出的机构是中心的,不一定是研究者的机构。硬x射线XAS研究将对金属蛋白、金属基药物、与金属诱发癌症相关的基因毒性物种和其他生物无机系统进行研究。将进行血红素蛋白研究,其中Fe - K-edge研究将集中在小分子与血红素的结合上,以了解影响这种结合是用作生物功能的开关,还是用于运输(或储存)小分子的因素。K-edge Cr XAS研究将用于确定与Cr诱导癌症相关的活性Cr(VI)、Cr(V)和Cr(IV)种冷冻溶液的结构。这些物质中的许多太活泼而不能结晶,只能在溶液中作为瞬态产生。同样,铬(III)配合物也被用作膳食补充剂和潜在的抗糖尿病药物,但活性物质的特征却很差。XAFS将被用于表征具有生物分子的中间体,这些生物分子被认为与此类膳食补充剂的生物转化有关。金属离子与黑色素结合是黑色素瘤细胞防止金属离子导致细胞死亡的重要途径,因为黑色素瘤细胞内含有较高浓度的H2O2, H2O2与金属离子反应产生毒素,杀死细胞,从而阻止黑色素瘤的生长。因此,我们利用K-edge XAFS研究金属离子与黑色素的结合及其在左旋多巴形成黑色素中的作用。最后,我们将研究Cu, Ni和Zn抗炎药物在药物制剂和人工胃液中的结构,以了解复合物的结构如何影响其疗效和副作用。通过了解它们在不同配方中的稳定性和结构,以及它们在模拟胃液中的生物转化,我们将优化药物配方,更好地了解这些药物的药理作用。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Hard X-ray XAS studies will be conducted on metalloproteins, metal-based drugs, genotoxic species of relevance to metal-induced cancers, and other bioinorganic systems. Heme protein studies will be conducted, in which Fe K-edge investigations will be focused on the binding of small molecules to the heme, in order to understand the factors that influence whether such binding is used as a switch in a biological function, or to transport (or store) the small molecule. K-edge Cr XAS studies will be used to determine the structures of frozen solutions of reactive Cr(VI), Cr(V) and Cr(IV) species of relevance to Cr-induced cancers. Many of these species are too reactive to be crystallized and can only be generated as transients in solution. Similarly, Cr(III) complexes are used as dietary supplements and potential anti-diabetics, but the active species are poorly characterized. XAFS will be used to characterize intermediates with biomolecules that are thought to be relevant to the biotransformations of such dietary supplements. The binding of metal ions to melanin is an important way in which melanoma cells prevent metal ions from leading to cell death, because melanoma cells contain relatively high intracellular concentration of H2O2 that reacts with metal ions to lead to toxins that would kill the cells and hence prevent the growth of melanomas. Hence are investigating the binding of metals ions to melanin and their roles in forming melanin from L-dopa using K-edge XAFS. Finally, we are investigating the structures of Cu, Ni and Zn anti-inflammatory drugs in pharmaceutical preparations and artificial gastric juices in order to understand how the structure of the complexes affects their efficacy and side-effects. By understanding their stabilities and structures in different formulations and their biotransformations in simulated gastric juices, we will optimize pharmaceutical formulations and gain a better understanding of the pharmacology of these drugs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
XAFS STUDIES OF METAL ANTI-DIABETIC SUPPLEMENTS AND DRUGS
  • 批准号:
    8362227
  • 项目类别:
  • 资助金额:
    $0.19万
  • 财政年份:
    2011
  • 负责人:
    PETER A LAY
  • 依托单位:
XAS STUDIES ON HEME PROTEINS
  • 批准号:
    8362228
  • 项目类别:
  • 资助金额:
    $0.33万
  • 财政年份:
    2011
  • 负责人:
    PETER A LAY
  • 依托单位:
XAFS STUDIES OF METAL ANTI-DIABETIC SUPPLEMENTS AND DRUGS
  • 批准号:
    8170187
  • 项目类别:
  • 资助金额:
    $0.27万
  • 财政年份:
    2010
  • 负责人:
    PETER A LAY
  • 依托单位:
XAS STUDIES ON HEME PROTEINS
  • 批准号:
    8170188
  • 项目类别:
  • 资助金额:
    $0.75万
  • 财政年份:
    2010
  • 负责人:
    PETER A LAY
  • 依托单位:
海外基金